Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer.

Lodge M, Pijls-Johannesma M, Stirk L, Munro AJ, De Ruysscher D, Jefferson T.

Radiother Oncol. 2007 May;83(2):110-22. Epub 2007 May 14. Review.

PMID:
17502116
2.

[Protons and ions in the treatment of cancer; a systematic review of the literature].

Pijls-Johannesma MC, de Ruysscher DK, Dekker AL, Lambin P.

Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2435-41. Review. Dutch.

PMID:
17131704
3.

Proton therapy - a systematic review of clinical effectiveness.

Olsen DR, Bruland OS, Frykholm G, Norderhaug IN.

Radiother Oncol. 2007 May;83(2):123-32. Epub 2007 May 11. Review.

PMID:
17499374
4.

How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.

Peeters A, Grutters JP, Pijls-Johannesma M, Reimoser S, De Ruysscher D, Severens JL, Joore MA, Lambin P.

Radiother Oncol. 2010 Apr;95(1):45-53. doi: 10.1016/j.radonc.2009.12.002. Epub 2010 Jan 26.

PMID:
20106540
5.

Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy.

Rong Y, Welsh J.

Am J Clin Oncol. 2010 Dec;33(6):646-9. doi: 10.1097/COC.0b013e3181cdf0fe. Review.

PMID:
20395789
6.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

7.

Particle beam therapy (hadrontherapy): basis for interest and clinical experience.

Orecchia R, Zurlo A, Loasses A, Krengli M, Tosi G, Zurrida S, Zucali P, Veronesi U.

Eur J Cancer. 1998 Mar;34(4):459-68. Review.

PMID:
9713294
8.

Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO).

Mayer R, Mock U, Jäger R, Pötter R, Vutuc C, Eiter H, Krugmann K, Hammer J, Hirn B, Hawliczek R, Knocke-Abulesz TH, Lukas P, Nechville E, Pakisch B, Papauschek M, Raunik W, Rhomberg W, Sabitzer H, Schratter-Sehn A, Sedlmayer F, Wedrich I, Auberger T.

Radiother Oncol. 2004 Dec;73 Suppl 2:S24-8.

PMID:
15971304
9.

[Proton and neutron radiation in cancer treatment: clinical and economic outcomes].

Fleurette F, Charvet-Protat S.

Bull Cancer Radiother. 1996;83 Suppl:223s-7s. Review.

PMID:
8949785
10.

On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma.

Jäkel O, Land B, Combs SE, Schulz-Ertner D, Debus J.

Radiother Oncol. 2007 May;83(2):133-8. Epub 2007 May 8. Review.

PMID:
17490770
11.

A challenge for high-precision radiation therapy: the case for hadrons.

Wambersie A, Auberger T, Gahbauer RA, Jones DT, Pötter R.

Strahlenther Onkol. 1999 Jun;175 Suppl 2:122-8.

PMID:
10394420
12.

Systematic review: charged-particle radiation therapy for cancer.

Terasawa T, Dvorak T, Ip S, Raman G, Lau J, Trikalinos TA.

Ann Intern Med. 2009 Oct 20;151(8):556-65. Epub 2009 Sep 14. Review.

PMID:
19755348
13.

Particle radiation therapy using proton and heavier ion beams.

Schulz-Ertner D, Tsujii H.

J Clin Oncol. 2007 Mar 10;25(8):953-64. Review.

PMID:
17350944
14.

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, Loeffler J, Clasie B, Safai S, Paganetti H.

Radiother Oncol. 2008 Feb;86(2):148-53. doi: 10.1016/j.radonc.2007.12.024. Epub 2008 Jan 30.

PMID:
18237800
15.

Current status of radiotherapy with proton and light ion beams.

Greco C, Wolden S.

Cancer. 2007 Apr 1;109(7):1227-38. Review.

16.

Prospects for proton-beam radiotherapy.

Nahum AE, Dearnaley DP, Steel GG.

Eur J Cancer. 1994;30A(10):1577-83. Review.

PMID:
7833122
17.

Basics of particle therapy: introduction to hadrons.

Welsh JS.

Am J Clin Oncol. 2008 Oct;31(5):493-5. doi: 10.1097/COC.0b013e31816a6237. Review.

PMID:
18838888
18.

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

Facey K, Bradbury I, Laking G, Payne E.

Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. Review.

19.

COST-ENLIGHT strategic workshop on hadron (particle) therapy, CERN, Geneva, 3-4 May 2007.

Taylor RE.

Br J Radiol. 2008 Mar;81(963):169-71. doi: 10.1259/bjr/91234292. Epub 2008 Jan 21.

PMID:
18208851
20.

Particle therapy in lung cancer: where do we stand?

Pijls-Johannesma M, Grutters JP, Lambin P, Ruysscher DD.

Cancer Treat Rev. 2008 May;34(3):259-67. doi: 10.1016/j.ctrv.2007.12.003. Epub 2008 Jan 15. Review.

PMID:
18226466
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk